Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2015
At a glance
- Drugs Bortezomib (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 10 Aug 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by Mayo Clinic record.
- 16 Apr 2014 Primary endpoint has been changed as reported by ClinicalTrials.gov record.